Global Medical REIT: Why I Skipped The Commons And 7.4% Yielding Preferreds

Global Medical REIT (GMRE) faces significant near-term refinancing liabilities on its $700 million debt, with an average term of 1.6 years, which is expected to pressure Funds From Operations (FFO) as debt is repriced at higher rates. Despite recent revenue growth and improved dividend coverage following a 29% dividend cut and a 1-for-5 reverse stock split, the REIT's constrained cash position and flat FFO growth make both common and preferred shares unattractive, leading to a 'hold' recommendation as it navigates this upcoming 'wall of refinancing' in a higher interest rate environment.

Analysis

Global Medical REIT (GMRE) faces a critical headwind from its near-term debt maturity profile, which overshadows recent operational performance. The REIT has approximately $700 million in total debt with a short weighted average term of 1.6 years and an average interest rate of 4.09%. This creates a significant refinancing risk, as this debt will likely be repriced at substantially higher rates, placing downward pressure on Funds From Operations (FFO) and free cash flow. While the company reported a 10.9% year-over-year revenue increase to $37.97 million for Q2 FY25, FFO per share remained flat at $1.00, indicating a lack of underlying earnings growth. A recent 29% dividend cut, combined with a one-for-five reverse stock split, has stabilized the payout; the new $3.00 annualized dividend is well-covered by the full-year FFO guidance of $4.45-$4.65 per share. However, this corrective action was necessitated by previous payouts exceeding FFO. The company's balance sheet remains constrained, with a cash position of just $9.23 million, providing a minimal buffer against its substantial debt obligations. Despite a diversified tenant base, the combination of stagnant FFO growth and the impending 'wall of refinancing' makes the current 8.9% dividend yield on the common stock appear risky.

Key Decisions for Investors

• Investors should exercise caution, as the primary risk is the imminent refinancing of $700 million in debt at higher interest rates, which is poised to compress FFO and potentially threaten future dividend coverage.
• Monitor upcoming quarterly reports for any signs of FFO per share growth, as the current flat trajectory offers no cushion to absorb the anticipated increase in interest expenses.
• Despite the high 8.9% yield, a 'hold' stance is warranted until there is greater clarity on the impact of refinancing; the risk of capital depreciation may outweigh the income potential in the near term.
• Between the common and preferred shares, the common stock may offer a better risk-reward profile, as the Series A preferreds (GMRE.PR.A) trade above their liquidation value, offering no margin of safety or significant upside potential.